Drucker, M., Aftandilian, C., Davis, K., Rheingold, S., Ball, D., Faulk, K., O'Brien, M., Stokke, J., Bhojwani, D., Kotecha, R., Rubinstein, J. (2025). A real-world multi-institution experience of standard vs alternative dosing of inotuzumab ozogamicin for Relapsed/Refractory pediatric B-cell acute lymphoblastic leukemia. Blood. https://doi.org/10.1182/blood-2025-1570